XERS - CIK 0001867096
Xeris Biopharma Holdings, Inc. has filed 290 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (129 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2025-08-13 | - |
| Insider trade | 4 | 2025-08-13 | 2025-08-12 |
| Insider sale notice | 144 | 2025-08-12 | - |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| Insider trade | 4 | 2025-08-04 | 2025-08-01 |
| Insider trade | 4 | 2025-08-04 | 2025-08-01 |
| Insider trade | 4 | 2025-06-16 | 2025-06-13 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-06-04 | 2025-06-04 |
| Major company event | 8-K | 2025-06-04 | 2025-06-04 |
| Major company event | 8-K | 2025-06-03 | 2025-06-03 |
| EFFECT | - | 2025-05-13 | - |
| Insider sale notice | 144 | 2025-05-09 | - |
| Company correspondence | CORRESP | 2025-05-09 | - |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Annual report to shareholders | ARS | 2025-04-23 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-23 | - |
| Proxy statement | DEF 14A | 2025-04-23 | 2024-12-31 |
| Insider trade | 4 | 2025-04-03 | 2025-04-02 |
| Insider trade | 4 | 2025-03-28 | 2025-03-28 |
| New insider ownership | 3 | 2025-03-28 | 2025-03-28 |
| Major company event | 8-K | 2025-03-28 | 2025-03-28 |
| Insider trade | 4 | 2025-03-21 | 2025-03-20 |
| Insider sale notice | 144 | 2025-03-20 | - |
| SEC correspondence | UPLOAD | 2025-03-11 | - |
| New insider ownership | 3 | 2025-03-07 | 2025-02-25 |
| Employee stock plan | S-8 | 2025-03-06 | - |
| Securities registration | S-3 | 2025-03-06 | - |
| Annual report | 10-K | 2025-03-06 | 2024-12-31 |
| Major company event | 8-K | 2025-03-06 | 2025-03-06 |
| Major company event | 8-K | 2025-02-24 | 2025-02-24 |
| Insider trade | 4 | 2025-02-03 | 2025-01-31 |
| Insider trade | 4 | 2025-02-03 | 2025-01-31 |
| Insider trade | 4 | 2025-02-03 | 2025-01-31 |
| Insider trade | 4 | 2025-02-03 | 2025-01-31 |
| Insider trade | 4 | 2025-02-03 | 2025-01-31 |
| Major company event | 8-K | 2025-01-10 | 2025-01-10 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2025-01-07 | 2025-01-03 |
| Insider trade | 4 | 2024-11-26 | 2024-11-22 |
| Quarterly report | 10-Q | 2024-11-08 | 2024-09-30 |